LD-2 disclosure · 3rd Quarter - Report
OCULAR SCIENCE/OSRX
Income$10Kfee reported
Client
- Description
- Biotech company operating a 503A drug compounding facility for eye products
- Location
- California · United States of America
Registrant
- Description
- Consulting, Lobbying and Government Affairs
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issuePharmacy
Outreach to Congress and Administration officials on FDA issues related to compound pharmacies and related matters
LobbyistsSONJA NESBIT
TargetedSENATE · HOUSE OF REPRESENTATIVES